Little you probably did not know about Oncotarget Journal

Oncotarget is a journal dedicated to providing the world with reliable information about the field of medicine. On establishment, the entire journal was devoted to offering a deep understanding of the examination and treatment of cancer. Oncotarget was founded in 2010 and is an open access journal.

Mikhail Blagosklonny and A.V. Gudkov are the editors in chief of the journal. Blagosklonny is a renowned scientist who dedicated his life to studying cancer and aging. Today, Blagosklonny works as a professor at the Rosewell Park Cancer Institute, New York. Through the help of these two scientists, Oncotarget has been in a position to continue publishing groundbreaking work.

The Oncotarget journal is reviewed on a weekly basis. Their posts are released online on a free access site to enable a maximum number of audiences. Primarily, they used to publish oncology papers only, but due to reliability by readers for providing accurate information, they opted to diversify. Today, they also cover other fields such as microbiology, pharmacology, neuroscience, and cardiology. Learn more about Oncotarget at Research Gate.

In 2011, Oncotarget was ranked as the best journal by Thompson Reuter JCR Impact Factor. The journal continues to hold the position up to date. The Journal has managed to beat all odds in the market because their posts have always remained well-organized for every reader to comprehend quickly. Also, having Blagosklonny and Gudkov as editors in the fields which they are passionate about, has made it possible for the journal to continue publishing not only accurate information but also that which is up to date. Additionally, Oncotarget understands the impact social media can influence. Therefore, they have ensured that their social media presence is felt in all the platforms available to provide a maximum audience outreach across the globe.

In the recent past, via Oncotarget, Rochester Medical Center published an article on the harmful effects of e-cigarette. The fact that e-cigarette has become a recent trend made this particular post so crucial. According to this study, a belief held by a majority that e-cigarette had no detrimental effects on their health was proven wrong. Dr. Irfan Rahman and his team found out that e-cigarette had long-term harmful effects on the user’s lungs and gum tissues. Also, recently Oncotarget published a post on the actual results of MET application in the gastric cancer treatment. Check Oncotarget journal at